Rethinking Dual Targeting, Durability After CAR-T in Non-Hodgkin Lymphoma - CancerNetwork
Rethinking Dual Targeting, Durability After CAR-T in Non-Hodgkin Lymphoma CancerNetwork
Rethinking Dual Targeting, Durability After CAR-T in Non-Hodgkin Lymphoma CancerNetwork
FDA Fully Approves Brexucabtagene Autoleucel (Tecartus) for Relapsed or Refractory Mantle Cell Lymphoma Oncology News Central
Non-Hodgkin lymphoma survivor thankful for clinical trial UT MD Anderson
Primary non-Hodgkin lymphoma in the muscle of left lower extremity: a case report and literature review Frontiers
Report: Counties that spray the most glyphosate have higher non-Hodgkin lymphoma rates Iowa Capital Dispatch
A Rare Case of Non-Hodgkin Lymphoma of the Tracheobronchial Tree Cureus
Miami F Marcus Allen has non-Hodgkin lymphoma, out for season ESPN
Long-term follow-up demonstrates the curative potential of dual CD19/CD22 CAR-T-cell therapy alone or combined with autologous stem cell transplantation in TP53-altered relapsed/refractory B-cell non-Hodgkin lymphoma | Signal Transduction and Targete Nature
Axi-Cel Shows Durable Responses, Curative Hope in Non-Hodgkin Lymphoma Targeted Oncology
New long-term analysis suggests follicular lymphoma can be cured Fred Hutchinson Cancer Center
Roundup Non-Hodgkin’s Lymphoma Lawsuit [2026 Update] robertkinglawfirm.com
Dave Coulier Reveals New Cancer Diagnosis Months After Beating Non-Hodgkin Lymphoma People.com
Stage IV non-Hodgkin lymphoma survivor: Why I’m excited about UT MD Anderson coming to Austin UT MD Anderson
Breast Mass as an Atypical Presentation of Non-Hodgkin Lymphoma Cureus
Levofloxacin for the prevention of febrile episodes in non-Hodgkin lymphoma patients treated with CHOP plus rituximab in a randomized controlled trial Nature
Case Report: A case of jejunal T-cell non-Hodgkin lymphoma with secondary bone involvement presenting as gastrointestinal perforation Frontiers
T-Cell Therapy EB103 Demonstrates Safety in B-Cell Non-Hodgkin Lymphoma Targeted Oncology
Hepatitis virus-associated B cell non-Hodgkin’s lymphoma involves dysregulated epigenetic and RNA-mediated regulatory gene expression and altered snoRNA transcription Nature
Non-Hodgkin's Lymphoma in Pregnancy: A Report of a Rare Case Cureus
Low-grade B-cell non-Hodgkin lymphoma in the sternocleidomastoid muscle: a case report and review of literature Frontiers
Non-Hodgkin Lymphoma and Tuberculosis Coexisting in the Same Cervical Lymph Node: A Case Report Cureus
Transformation of Classical Hodgkin Lymphoma Into Non-Hodgkin Lymphoma: Three Case Reports From the West Bank Wiley Online Library
Axicabtagene Ciloleucel in Relapsed or Refractory Indolent Non-Hodgkin Lymphoma: 5-Year Follow-up of ZUMA-5 The ASCO Post
Non-Hodgkin lymphoma and HIV Aidsmap
Clinical characteristics and short-term outcomes of pediatric lymphoma: a retrospective cohort study from a large tertiary hospital in a low- and middle-income country Nature
Groundbreaking treatment fighting back against Non-Hodgkin’s Lymphoma KPLC 7 News
Bayer settles Broward weedkiller case as legal battles loom in other states, Supreme Court WUSF
Computational screening and in vitro evaluation of sphingosine-1-phosphate analogues as therapeutics for Non-Hodgkin’s lymphoma Nature
Non-Hodgkin lymphoma survival rate: Outlook and more Medical News Today
Primary Non-Hodgkin Lymphoma of the Urinary Bladder in the Paediatric Age Group: A Report of a Rare Case Cureus
Lymphocyte Kinetics After CAR T-Cell Infusion May Predict Survival Outcomes in Non-Hodgkin Lymphoma The ASCO Post
New treatment combination offers excellent results for early-stage Hodgkin lymphoma with less chemotherapy UT MD Anderson
Safety and efficacy of autologous humanized CD19 CAR-T cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma Nature
FDA Approves CAR-T Therapy for Marginal Zone Lymphoma Oncology News Central
Non-Hodgkin Lymphoma (NHL): Jon and Julie's Story BMT infonet.org
Elucidating Bispecific Impact in Diffuse Large B-Cell Lymphoma CancerNetwork
Primary Pulmonary Non-Hodgkin Lymphoma: A Report of Two Cases and a Review of the Literature Emphasizing the Role of Radiotherapy Cureus
ASH 2025 | Congress coverage: Indolent and mantle cell NHL Lymphoma Hub
Primary extranodal marginal zone non-hodgkin lymphoma of the prostate: a case report Frontiers
CELMoDs for the treatment of non-Hodgkin lymphoma Lymphoma Hub